This CPB has been revised to state that intravascular MRI is considered experimental and investigational for detecting coronary vulnerable plaques. This policy revision is supported by an assessment by the Agency for Healthcare Research and Quality. This CPB is revised to state that whole-heart coronary MRI is considered experimental and investigational for the non-invasive evaluation of the coronary arteries.